Ozempic and Wegovy Pose a Threat to WeightWatchers and Noom - Bloomberg

The Disruptive Power of Weight Loss Drugs Is Being Felt Beyond Pharma - The New York Times

The Year Ozempic, Wegovy and More Weight-Loss Drugs Ate the News - Bloomberg

The Year Ozempic, Wegovy and More Weight-Loss Drugs Ate the News - Bloomberg

Ozempic's Surging Popularity Has Novo Nordisk (NVO) Struggling to Meet Demand - Bloomberg

Ozempic, Wegovy Obesity Drugs Look Like Lifelong Weight Loss Treatments - Bloomberg

EU Asks for Details on Anesthesia Risks for Weight-Loss, Diabetes Drugs - Bloomberg

Ozempic's Surging Popularity Has Novo Nordisk (NVO) Struggling to Meet Demand - Bloomberg

Noom Names Geoff Cook as New CEO as Startup Shifts to Weight-Loss Drugs - Bloomberg

Ozempic's Cost: Weight Loss Drugs Will Be Billed to US Taxpayers - Bloomberg